Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC)

CUSIP: G7487R100

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Ordinary Shares, $0.00001 Par Value
Shares outstanding
494,239,409
Total 13F shares
8,498
Share change
-11,747
Total reported value
$296,000
Price per share
$34.60
Number of holders
5
Value change
-$146,385
Number of buys
5
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP G7487R100?
CUSIP G7487R100 identifies RGC - Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC) as of Q2 2022

As of 30 Jun 2022, Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,498 shares. The largest 5 holders included GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC), BlackRock Inc., and MORGAN STANLEY. This page lists 5 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.